These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 20303183
1. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis. Rodrigues DH, Vilela MC, Barcelos LS, Pinho V, Teixeira MM, Teixeira AL. J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183 [Abstract] [Full Text] [Related]
2. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. Dos Santos AC, Roffê E, Arantes RM, Juliano L, Pesquero JL, Pesquero JB, Bader M, Teixeira MM, Carvalho-Tavares J. J Neuroinflammation; 2008 Nov 05; 5():49. PubMed ID: 18986535 [Abstract] [Full Text] [Related]
3. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis--an intravital microscopy study. dos Santos AC, Barsante MM, Arantes RM, Bernard CC, Teixeira MM, Carvalho-Tavares J. J Neuroimmunol; 2005 May 05; 162(1-2):122-9. PubMed ID: 15833367 [Abstract] [Full Text] [Related]
4. Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis. Rodrigues DH, Lacerda-Queiroz N, de Miranda AS, Fagundes CT, Campos RD, Arantes RE, Vilela Mde C, Rachid MA, Teixeira MM, Teixeira AL. Brain Res; 2011 Apr 18; 1385():298-306. PubMed ID: 21338585 [Abstract] [Full Text] [Related]
5. PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. Berod L, Heinemann C, Heink S, Escher A, Stadelmann C, Drube S, Wetzker R, Norgauer J, Kamradt T. Eur J Immunol; 2011 Mar 18; 41(3):833-44. PubMed ID: 21287545 [Abstract] [Full Text] [Related]
6. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE). Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS. J Neuroimmunol; 2008 Oct 15; 203(1):79-93. PubMed ID: 18687476 [Abstract] [Full Text] [Related]
7. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. Prasad R, Giri S, Nath N, Singh I, Singh AK. J Neurosci Res; 2006 Aug 15; 84(3):614-25. PubMed ID: 16770773 [Abstract] [Full Text] [Related]
10. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs. Thakker P, Marusic S, Stedman NL, Lee KL, McKew JC, Wood A, Goldman SJ, Leach MW, Collins M, Kuchroo VK, Wolf SF, Clark JD, Hassan-Zahraee M. J Immunol; 2011 Aug 15; 187(4):1986-97. PubMed ID: 21746963 [Abstract] [Full Text] [Related]
11. Increased thrombin inhibition in experimental autoimmune encephalomyelitis. Beilin O, Karussis DM, Korczyn AD, Gurwitz D, Aronovich R, Hantai D, Grigoriadis N, Mizrachi-Kol R, Chapman J. J Neurosci Res; 2005 Feb 01; 79(3):351-9. PubMed ID: 15605378 [Abstract] [Full Text] [Related]